|

Omnipaque 350mgI/mL Solution for Injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Alison Stopeck1

Indications

  • Neoadjuvant Chemotherapy1
  • TNBC - Triple-Negative Breast Cancer1
  • Locally Advanced Breast Cancer1
  • Triple Negative Breast Cancer1
  • HER2-positive Breast Cancer1

Stony Brook, New York1 trial

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Stony Brook Breast Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.